News
| 2 min read
Roche's faricimab injected every 16 weeks proves non-inferior to aflibercept injected every eight weeks in patients with “wet” age-related macular degeneration
| 2 min read
The anticoagulant drug could be repurposed for COVID-19 treatment
| 5 min read
Well-established assay formats that can be used throughout the development continuum are a great benefit to researchers
| 2 min read
New York Institute of Technology secures $1.8M grant to investigate vascular decalcification
| 3 min read
The European Commission has approved AbbVie’s RINVOQ (upadacitinib) for treatment of psoriatic arthritis and ankylosing spondylitis
| 2 min read
Researchers have established a new sensory neuron model that could replace animal models
| 2 min read
Kiromic’s GMP manufacturing facility in Houston will support the company’s first-in-human allogenic CAR-T trial
| 2 min read
Acquisition will expand Thermo Fisher’s global capacity for cell and gene therapies
| 3 min read
Researchers have linked a cellular transport pathway to glioblastoma multiforme
| 2 min read
GRAIL announces collaborations with three industry giants to evaluate its platform in cancer MRD testing
| 3 min read
Company shares plans to spin out oncology business and retain severe genetic disease business
| 3 min read
The companies are aiming to develop a new production-scale platform to expand clinical adoption of whole-genome sequencing
